483 related articles for article (PubMed ID: 33142045)
1. Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges.
Yang Y; Deng X; Li Q; Wang F; Miao L; Jiang Q
Cancer Commun (Lond); 2020 Dec; 40(12):655-680. PubMed ID: 33142045
[TBL] [Abstract][Full Text] [Related]
2. Functions and roles of long noncoding RNA in cholangiocarcinoma.
Li J; Huang L; Li Z; Zhong X; Tai S; Jiang X; Cui Y
J Cell Physiol; 2019 Aug; 234(10):17113-17126. PubMed ID: 30888066
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH
Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide identification of a competing endogenous RNA network in cholangiocarcinoma.
Li G; Liu T; Zhang B; Chen W; Ding Z
J Cell Biochem; 2019 Nov; 120(11):18995-19003. PubMed ID: 31270845
[TBL] [Abstract][Full Text] [Related]
5. Role of noncoding RNAs in cholangiocarcinoma (Review).
Lv Y; Wang Z; Zhao K; Zhang G; Huang S; Zhao Y
Int J Oncol; 2020 Jul; 57(1):7-20. PubMed ID: 32319584
[TBL] [Abstract][Full Text] [Related]
6. Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes.
Han BW; Ye H; Wei PP; He B; Han C; Chen ZH; Chen YQ; Wang WT
BMC Genomics; 2018 Oct; 19(1):735. PubMed ID: 30305026
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma.
Song W; Miao DL; Chen L
Biochem Biophys Res Commun; 2018 Dec; 506(4):1004-1012. PubMed ID: 30404735
[TBL] [Abstract][Full Text] [Related]
8. Circular RNAs in cholangiocarcinoma.
Liao W; Feng Q; Liu H; Du J; Chen X; Zeng Y
Cancer Lett; 2023 Jan; 553():215980. PubMed ID: 36336149
[TBL] [Abstract][Full Text] [Related]
9. Non-Coding RNA in Cholangiocarcinoma: An Update.
Li J; Bao H; Huang Z; Liang Z; Lin N; Ni C; Xu Y
Front Biosci (Landmark Ed); 2023 Aug; 28(8):173. PubMed ID: 37664914
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression.
Yu Y; Chen Q; Zhang X; Yang J; Lin K; Ji C; Xu A; Yang L; Miao L
Cancer Sci; 2020 Jul; 111(7):2297-2309. PubMed ID: 32378752
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
[TBL] [Abstract][Full Text] [Related]
12. LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner.
Wang WT; Ye H; Wei PP; Han BW; He B; Chen ZH; Chen YQ
J Hematol Oncol; 2016 Nov; 9(1):117. PubMed ID: 27809873
[TBL] [Abstract][Full Text] [Related]
13. The roles of epigenetic regulation in cholangiocarcinogenesis.
Zhong B; Liao Q; Wang X; Wang X; Zhang J
Biomed Pharmacother; 2023 Oct; 166():115290. PubMed ID: 37557012
[TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of lncRNA-related prognostic signatures in cholangiocarcinoma.
Li F; Zhang J; Zhang J; Xue H; Liu L; Yang Z; Dong H; Wang K
Genomics; 2023 May; 115(3):110621. PubMed ID: 37068643
[TBL] [Abstract][Full Text] [Related]
15. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
Zhou D; Gao B; Yang Q; Kong Y; Wang W
Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187
[TBL] [Abstract][Full Text] [Related]
16. LncRNA LINC01061 sponges miR-612 to regulate the oncogenic role of SEMA4D in cholangiocarcinoma.
Yu A; Zhao L; Kang Q; Chen K; Li J; Fu H; Liu J; Zhang X
Biochem Biophys Res Commun; 2019 May; 513(2):465-471. PubMed ID: 30967271
[TBL] [Abstract][Full Text] [Related]
17. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
Qiu G; Ma D; Li F; Sun D; Zeng Z
Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
[TBL] [Abstract][Full Text] [Related]
18. Role of long non-coding RNAs in cholangiocarcinoma: A systematic review and meta-analysis.
Shobeiri P; Arabzadeh Bahri R; Khadembashiri MM; Khadembashiri MA; Maleki S; Eslami M; Khalili Dehkordi M; Behnoush AH; Rezaei N
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2029. PubMed ID: 38517409
[TBL] [Abstract][Full Text] [Related]
19. Identifying survival-associated ceRNA clusters in cholangiocarcinoma.
Wan M; Zhang FM; Li ZL; Kang PC; Jiang PM; Wang YM; Wang ZD; Zhong XY; Li CL; Wang H; Zhao SY; Cui YF
Oncol Rep; 2016 Sep; 36(3):1542-50. PubMed ID: 27432084
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo.
Yao Y; Sun Y; Jiang Y; Qu L; Xu Y
Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]